NEUROPROTECTION BY CORTICOTROPIN-RELEASING FACTOR DURING HYPOXIA IN RAT-BRAIN

被引:45
作者
FOX, MW
ANDERSON, RE
MEYER, FB
机构
[1] MAYO CLIN & MAYO FDN,DEPT NEUROSURG,CEREBRAL VASC RES LAB,200 1ST ST SW,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO GRAD SCH MED,ROCHESTER,MN 55901
关键词
HYPOXIA; NEUROPEPTIDES; NEUROPROTECTION; RATS;
D O I
10.1161/01.STR.24.7.1072
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose: Corticotropin releasing factor is an endogenous neuropeptide released by the hypothalamus that activates the pituitary-adrenocortical system in response to stressful stimuli. It has been demonstrated that corticotropin releasing factor increases the excitability of hippocampal neurons in both in vitro and in vivo studies, which may contribute to neurological injury during hypoxia. The purpose of this study was to determine the effects of corticotropin releasing factor and its synthetic competitive antagonist, alpha-CRF, on neuronal synaptic recovery after a hypoxic insult using the hippocampal slice. Methods: Wistar rat hippocampal brain slices (n = 120) were treated with various concentrations (10(-6) to 10(-11)) of corticotropin releasing factor or its synthetic antagonist during a 10-minute hypoxic episode. Extracellular recording of population spikes was used during and after the hypoxic insult to assess neuronal recovery. Results: Corticotropin releasing factor provided dose-dependent neuronal protection with maximum recovery (37.95+/-8.71%) occurring at 10-(9) concentrations. The competitive antagonist alpha-CRF provided a similar degree of recovery at 10(-6) concentration, whereas 10(-9) molar concentration of competitive antagonist resulted in 16.84+/-7.68% recovery. Conclusions: Corticotropin releasing factor provides moderate protection to hypoxic hippocampal neurons in the brain slice preparation. The mechanism of action is unknown but appears to be a direct neuronal effect. These results support the hypothesis that corticotropin releasing factor may act as an endogenous neuroprotective hormone during hypoxia.
引用
收藏
页码:1072 / 1075
页数:4
相关论文
共 38 条
[1]   RECEPTOR-MEDIATED ACTIONS OF CORTICOTROPIN-RELEASING FACTOR IN PITUITARY-GLAND AND NERVOUS-SYSTEM [J].
AGUILERA, G ;
WYNN, PC ;
HARWOOD, JP ;
HAUGER, RL ;
MILLAN, MA ;
GREWE, C ;
CATT, KJ .
NEUROENDOCRINOLOGY, 1986, 43 (01) :79-88
[2]   DOES CORTICOTROPIN RELEASING-FACTOR ACT VIA A CALCIUM-DEPENDENT MECHANISM [J].
ALDENHOFF, JB .
PSYCHONEUROENDOCRINOLOGY, 1986, 11 (02) :231-236
[3]   CORTICOTROPIN RELEASING-FACTOR DECREASES POSTBURST HYPERPOLARIZATIONS AND EXCITES HIPPOCAMPAL-NEURONS [J].
ALDENHOFF, JB ;
GRUOL, DL ;
RIVIER, J ;
VALE, W ;
SIGGINS, GR .
SCIENCE, 1983, 221 (4613) :875-877
[4]   STRESS HORMONES - THEIR INTERACTION AND REGULATION [J].
AXELROD, J ;
REISINE, TD .
SCIENCE, 1984, 224 (4648) :452-459
[5]  
BRITTONTHATCHER K, 1983, BRAIN RES, V369, P303
[6]   CORTICOTROPIN-RELEASING FACTOR RECEPTOR ANTAGONIST - EFFECTS ON THE AUTONOMIC NERVOUS-SYSTEM AND CARDIOVASCULAR FUNCTION [J].
BROWN, MR ;
GRAY, TS ;
FISHER, LA .
REGULATORY PEPTIDES, 1986, 16 (3-4) :321-329
[7]  
CHEN FM, 1986, BRAIN RES, V381, P49
[8]  
DESOUZA EB, 1985, J NEUROSCI, V5, P3189
[9]   THE RAT HIPPOCAMPAL SLICE PREPARATION AS AN INVITRO MODEL OF ISCHEMIA [J].
DONG, WQ ;
SCHURR, A ;
REID, KH ;
SHIELDS, CB ;
WEST, CA .
STROKE, 1988, 19 (04) :498-502
[10]   LOW-DOSE ALTERNATE-DAY CORTICOTROPIN THERAPY IN THE TREATMENT OF CHILDHOOD SEIZURES [J].
DOOLEY, JM ;
CAMFIELD, PR ;
GOULDEN, KJ ;
MACKEN, SR .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (11) :1263-1265